Evidence map›Paper›PMID 40087767›Full record

Trial reportHarm reduction journal2025

Social support and HIV management among people who inject drugs: in-depth interviews in Delhi, India.

Rose P Kaptchuk, Aastha Kant, Surendra S Shekhawat, Jiban Baishya, Archit Sinha, Ashwini Kedar, Saisha Khanna, Allison M McFall, Sunil S Solomon, Shruti H Mehta and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rose P KaptchukJohns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA. rosepk@jhu.edu.
Aastha KantJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Surendra S ShekhawatYR Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Jiban BaishyaJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Archit SinhaYR Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Ashwini KedarYR Gaitonde Centre for AIDS Research and Education (YRG CARE), Chennai, India.
Saisha KhannaJohns Hopkins Krieger School of Arts and Sciences, Baltimore, MD, USA.
Allison M McFallJohns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Sunil S SolomonJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Shruti H MehtaJohns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA.
Gregory M LucasJohns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

PWID Opportunities to Improve TrEat and Retain (POINTER)R01DA049301 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2020 to 2025
$4.8M
Treatment outcomes and comorbidity in HIV-infected IDUK24DA035684 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M · 2014 to 2024
$1.5M
NIDA NIH HHS K24 DA035684NIDA NIH HHS R01 DA049301NIH HHS R01 DA049301
6 · The paper itself

Abstract

backgroundPeople who inject drugs (PWID) experience a higher burden of HIV compared to general populations. Social support has been shown to improve disease management and combat stigma for PWID yet remains unexplored among PWID in low- and middle-income countries.

methodsWe conducted qualitative in-depth interviews to understand social ties and health management among PWID living with HIV in Delhi, India. The research was nested in a factorial randomized controlled trial comparing same-day treatment and community-based care with standard-of-care. Interviews were conducted in Hindi in a private room, audio recorded, transcribed in English, and analyzed inductively using Dedoose.

resultsWe conducted 22 interviews (30 min-two hours) with PWID living with HIV in Delhi (all men, ages 21-38 years). 10 slept in houses, 11 on public streets, and one in a shelter. Participants often experienced isolation in their lives but identified avenues of positive social support from healthcare staff, families, peers (friends or injecting partners), and authority figures/public contacts. Healthcare staff provided information and respectful encouragement to manage health. Outreach workers provided support to remind and accompany participants to clinic visits. Family members offered financial support, medicine reminders, and trust. Authority figures/public contacts included employers, shopkeepers, and vendors who provided a safe place to sleep or store belongings, which proved crucial to consistently store and take pills. In some cases, specific social connections created barriers to health by enabling injecting drug use and carrying out harmful behaviors such as physical attacks, disrespect, and theft.

conclusionSocial connections can offer PWID positive emotional and logistical support to access health services and help them persevere through societal and structural stigmas. However, in some cases they may also contribute negatively to health management challenges. As a harm reduction strategy, public health services can work with PWID to consider untapped opportunities to build positive support and resilience through social ties, as well as how to contend with social connections harmful to health management.

Indexed as

HIV InfectionsSocial SupportSubstance Abuse, IntravenousAdultHarm ReductionHumansIndiaInterviews as TopicMaleQualitative ResearchSocial StigmaYoung AdultHarm reductionHIVIndiaPWIDSocial support

Identifiers

PMID40087767
PMCPMC11909935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.